Ketamine-HCl-NMDA-Antagonist

Ketamine HCl NMDA Antagonist: Advanced Neuro-Research Standards

Leverage the pharmacological precision of a high-purity Ketamine HCl NMDA Antagonist. As a potent non-competitive antagonist at the N-methyl-D-aspartate (NMDA) receptor, this compound is essential for research into synaptogenesis, the mTOR pathway, and dissociative anesthesia. Our USP-grade vials (100mg/mL) are identified by CAS 1867-66-9, ensuring 99.9% molecular purity for institutional clinical trials and veterinary surgery.

LyfeUnit provides a secure procurement layer for professional researchers. We optimize your supply chain with discreet US shipping and institutional wholesale pricing. By utilizing cryptocurrency payments (BTC, XMR, ETH), we ensure 100% transaction privacy and a 5% discount at checkout. Our inventory is HPLC-verified, providing the sterile, non-pyrogenic consistency required for published scientific results and precise clinical induction.

• ✓ Mechanism: Non-competitive NMDA Receptor Antagonism
• ✓ Purity: 99.9% HPLC-Verified USP Pharmaceutical Grade
• ✓ Logistics: Tracked, 2-3 day domestic US stealth shipping and 4-7 days internationally.
• ✓ Payment: Encrypted BTC/XMR/ETH with 5% privacy discount

Technical Note: Schedule III controlled substance. For use by licensed professionals only. Review technical toxicology data at PubChem.